tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Stock Investors

Compare
792 Followers
Based on 793,549 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ARQT
On average, investors allocate 4.42% of their portfolios to ARQT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,549 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ARQT

10.4%
Last 7
Days
40.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ARQT, out of 793,549 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ARQT Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$8.31
Reduced
0.24%
$14.56
Reduced
2.97%
$15.27
Increased
3.74%
$13.21
Opened
0.00%
$12.31
Opened
0.54%
$12.51
Increased
2.28%
$13.40
Increased
0.47%
$16.60
Increased
0.06%
$15.93
Opened
5.88%
$16.60
Based on the activity of investors who made their portfolios public
The table shows changes in ARQT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ARQT Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.88%
-0.35%
-6.95%
3.14B
Healthcare
Celestica
5.17%
+1.89%
+0.97%
10.17B
Technology
Block
3.68%
+0.06%
-0.76%
37.99B
Technology
Wells Fargo
3.73%
+0.23%
+2.86%
239.89B
Financial
Zscaler
3.50%
+0.06%
-4.36%
33.38B
Technology
Nio
8.92%
-0.50%
-4.77%
9.01B
Consumer Cyclical
Riot Platforms
4.62%
-0.30%
-5.57%
2.98B
Financial
PDD Holdings
4.90%
-0.75%
-6.40%
173.94B
Consumer Cyclical
Raytheon Technologies
3.80%
+0.37%
+0.27%
181.12B
Industrials
Marathon Digital Holdings
5.01%
-0.01%
-3.64%
4.93B
Financial
Based on the activity of 793,549 active portfolios
Open your Smart Portfolio

ARQT Investor Analysis

ARQT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.2%
of ARQT holders
are under 35
Average Segment Performance
Average P/E Ratio18.15
Beta11.20
Dividend Yield3.92%
ARQT investors between 35–55

Between 35–55

39.1%
Last 30 days
Holdings Change
41.6%
of ARQT holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.89
Beta22.53
Dividend Yield3.38%
ARQT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
47.2%
of ARQT holders
are over 55
Average Segment Performance
Average P/E Ratio13.53
Beta11.97
Dividend Yield3.63%
Overview of age group and performance of ARQT stock investors
See who invests in ARQT according to age group and performance.

FAQ

How many retail Investors hold ARQT?
<0.1% of TipRanks' retail investors hold ARQT in their portfolios.
    What is ARQT Investor Sentiment?
    ARQT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ARQT in the last 7 days?
      ▲ 10.4% of TipRanks' retail investors changed their holding of ARQT in the last 7 days.
        What percentage of retail investors changed their holding of ARQT in the last 30 days?
        ▲ 40.1% of TipRanks' retail investors changed their holding of ARQT in the last 30 days.
          What is the average age of retail investors who hold ARQT?
          The average age of ARQT Holders is over 55.
            What other stocks have ARQT investors also bought?
            ARQT Investors also bought VKTX, CLS, XYZ, WFC, ZS, NIO, RIOT, PDD, RTX, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALGNAlign Tech
              ALKSAlkermes
              AZNAstraZeneca
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis